KalVista Pharmaceuticals, Inc. 4
4 · KalVista Pharmaceuticals, Inc. · Filed Mar 27, 2017
Insider Transaction Report
Form 4
Unkart Edward W
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2017-03-23+12,000→ 12,000 totalExercise: $7.88Exp: 2027-03-22→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The option vests over a 3 year period: 1/36th on December 21, 2016 after which 1/36th of the total shares vest monthly, subject to continued service through each vesting date.